Aram Andrew Mangasarian holds the position of Chief Executive Officer for TME Pharma NV and Chief Executive Officer & Non-Executive Director at NOXXON Pharma AG (a subsidiary of TME Pharma NV).

He is also on the board of Isofol Medical AB and NOXXON Pharma NV Niederlassung Deutschland and Chief Executive Officer & Non-Executive Director at NOXXON Pharma AG.

He previously was Vice President-Business Development of Eurobio-Scientific SA and Vice President-Business Development for Exonhit (a subsidiary of Eurobio-Scientific SA) and Vice President-Business Development at Novexel SA.

Dr. Mangasarian received an MBA from INSEAD, a doctorate from the University of California San Diego and an undergraduate degree from the University of Wisconsin.